BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, February 8, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

Bench Press: BioWorld looks at translational medicine

July 17, 2017
By Anette Breindl
Fanconi anemia is a genetic disorder that leads to bone marrow failure, and also predisposes individuals to developing certain types of cancer. Fanconi anemia is caused by mutations in DNA repair genes, though it does not map neatly onto a particular DNA repair pathway.
Read More

Measuring 'watery fat' improves CT readouts

July 13, 2017
By Anette Breindl

Measuring 'watery fat' improves value of CT readouts

July 13, 2017
By Anette Breindl
A new way of analyzing computerized tomography (CT) angiography, the standard method for imaging blood vessels to look for potential blockages, could help find future trouble spots before they are causing trouble.
Read More

Personalized cancer vaccines succeed in two early trials

July 10, 2017
By Anette Breindl

Bench Press: BioWorld looks at translational medicine

July 10, 2017
By Anette Breindl
By screening for glioblastoma targets in vivo using mouse models with patient-derived xenografts, researchers have identified new potential targets for drugs to treat glioblastoma.
Read More

Personalized cancer vaccines succeed in two early trials

July 6, 2017
By Anette Breindl
Two groups reported that vaccinating melanoma patients with personalized, tumor-specific antigens led to progression-free survival in the majority of patients over roughly two years of follow-up. The results were reported in back-to-back papers in the July 6, 2017, issue of Nature.
Read More

Lack of epigenetic enzyme leaves neurons a TAD disorganized

July 5, 2017
By Anette Breindl
Changes in the 3-D organization of chromosomes in neurons affected the expression of genes that are important for the formation of neuronal connections and that have been implicated in schizophrenia risk, researchers at the Mount Sinai School of Medicine reported in the July 3, 2017, issue of Nature Genetics.
Read More

Bench Press: BioWorld looks at translational medicine

July 3, 2017
By Anette Breindl
Researchers from the International Mouse Phenotypic Consortium have published the comprehensive phenotypes of more than 3,300 knockout mice, describing mouse models for 360 diseases.
Read More

Big data brings big challenges, big opportunities

June 22, 2017
By Anette Breindl

SAN DIEGO – At the State of Innovation session during BIO 2017, a brief exchange neatly summed up the current status of big data. Noting that clinical trial expenses and success rates have not changed appreciably as the amount of data that is collected from patients, most prominently but not only through genome sequencing, has increased, venture capital firm Flagship Pioneering's Jeremy Springhorn lamented that "there's all this information out there, yet we're not using it."


Read More

Putting the liver to work makes quick bispecifics

June 22, 2017
By Anette Breindl
Previous 1 2 … 147 148 149 150 151 152 153 154 155 … 400 401 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 6, 2025.
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Brain and DNA

    REST emerges as biomarker in ALS, knockdown improves ALS symptoms

    BioWorld Science
    About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
  • Brain illustrated with pills

    Serotonin receptor modulators for the treatment of OUD

    BioWorld Science
    Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
  • Liver anatomy illustration

    KLF15 shows potential as marker, target for cholangiocarcinoma

    BioWorld Science
    Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing